Seven Eight Capital, LP Royalty Pharma PLC Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $500,883 - $598,542	-19,074 Reduced 59.79%	12,830 $348,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $944,358 - $1.17 Million	31,904 New	31,904 $980,000
Q4 2022 Feb 13, 2023	SELL	$39.17 - $44.04 $60,086 - $67,557	-1,534 Reduced 10.96%	12,465 $492,000
Q3 2022 Nov 10, 2022	BUY	$39.88 - $44.65 $558,280 - $625,055	13,999 New	13,999 $562,000
Q2 2022 Aug 04, 2022	SELL	$37.53 - $44.22 $305,306 - $359,729	-8,135 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$37.46 - $42.44 $304,737 - $345,249	8,135 New	8,135 $317,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.